Asunto(s)
Alopecia/etiología , Adulto , Factores de Edad , Edad de Inicio , Anciano , Anciano de 80 o más Años , Alopecia/tratamiento farmacológico , Índice de Masa Corporal , Estudios Transversales , Escolaridad , Femenino , Fibrosis , Humanos , Persona de Mediana Edad , Factores de Riesgo , Índice de Severidad de la EnfermedadRESUMEN
BACKGROUND: Frontal fibrosing alopecia (FFA) is a chronic cicatricial alopecia with an increasing incidence and unknown aetiology. AIM: To identify possible environmental and hormonal factors related to FFA. METHODS: We conducted a multicentre case-control study paired by sex and age, and recruited 664 women (335 cases and 329 controls) and 106 men (20 cases and 86 controls). Study subjects completed an exhaustive questionnaire enquiring about pharmacological, environmental, hormonal, social, job exposure, lifestyle, drugs and diet factors to which they were exposed at least 5 years prior to the onset of the disease. RESULTS: For women, there was a statistical association between alopecia and history of pregnancy (OR = 1.6; 95% CI 1.06-2.41), use of facial sunscreen (OR = 1.6; 95% CI 1.06-2.41) and hormone replacement therapy (HRT) (OR = 1.76; 95% CI 1.11-2.8) or raloxifene (no controls exposed therefore OR was not calculated), exposure to alkylphenolic compounds (OR = 1.48; 95% CI 1.05-2.08), and presence of rosacea (OR = 1.91; 95% CI 1.07-3.39), lichen planus pigmentosus (LPP) (OR = 5.14; 95% CI 1.11-23.6) or hypothyroidism (OR = 1.73; 95% CI 1.11-2.69). For men, there was a statistical association between alopecia and use of facial sunscreens (OR = 11.6; 95% CI 1.7-80.9) or antiageing creams (OR = 1.84; 95% CI 1.04-3.23). CONCLUSIONS: FFA seems to be associated with hormonal exposure (pregnancy, HRT and raloxifene), comorbidities (hypothyroidism, LPP and rosacea) and environmental factors (facial sunscreens, antiageing creams and occupational exposure). Further research is required to analyse the exact mechanism in which these environmental factors participate in the development of this alopecia.
Asunto(s)
Alopecia/patología , Fibrosis/patología , Frente/patología , Protectores Solares/efectos adversos , Adulto , Anciano , Anciano de 80 o más Años , Alopecia/inducido químicamente , Alopecia/etiología , Estudios de Casos y Controles , Comorbilidad , Antagonistas de Estrógenos/efectos adversos , Femenino , Fibrosis/etiología , Terapia de Reemplazo de Hormonas/efectos adversos , Humanos , Liquen Plano/complicaciones , Masculino , Persona de Mediana Edad , Exposición Profesional/efectos adversos , Clorhidrato de Raloxifeno/efectos adversos , Factores de RiesgoRESUMEN
Hair and scalp evaluation techniques can be classified into 3 categories: noninvasive methods (clinical history, general examination, inspection and palpation of the hair and scalp, photography, dermoscopy, etc.); semi-invasive methods (the trichogram); and invasive methods (biopsy). In this article, we provide a practical guide on how to evaluate hair and scalp conditions in the dermatology office.
Asunto(s)
Dermoscopía , Enfermedades del Cabello/patología , Dermatosis del Cuero Cabelludo/patología , HumanosAsunto(s)
Porocarcinoma Ecrino/diagnóstico , Neoplasias de las Glándulas Sudoríparas/diagnóstico , Antígeno Carcinoembrionario/metabolismo , Complicaciones de la Diabetes , Porocarcinoma Ecrino/patología , Porocarcinoma Ecrino/cirugía , Femenino , Humanos , Queratinas/metabolismo , Antígeno Ki-67/metabolismo , Neoplasias de las Glándulas Sudoríparas/patología , Neoplasias de las Glándulas Sudoríparas/cirugía , Resultado del TratamientoRESUMEN
A 45-year-old woman with personal history of hypertension presented with an erythematous lesion in the neckline for a year and with a progressive growth. A physical examination revealed an annular lesion with erythematous papules in the edge. Histological exam showed phagocytosis of elastic fibers by multinucleated cells compatible with annular elastolytic giant-cell granuloma. The patient did not present any other associated systemic manifestation. Treatment with tacrolimus 0.1 percent ointment was prescribed with a very good response after two months.
Asunto(s)
Eritema/patología , Granuloma de Células Gigantes/patología , Enfermedades de la Piel/patología , Eritema/tratamiento farmacológico , Femenino , Granuloma de Células Gigantes/tratamiento farmacológico , Humanos , Inmunosupresores/uso terapéutico , Persona de Mediana Edad , Enfermedades de la Piel/tratamiento farmacológico , Tacrolimus/uso terapéuticoAsunto(s)
Anticoagulantes/uso terapéutico , Bencimidazoles/uso terapéutico , Obesidad Mórbida/complicaciones , Piridinas/uso terapéutico , Trombosis de la Vena/tratamiento farmacológico , Acenocumarol/efectos adversos , Acenocumarol/uso terapéutico , Anticoagulantes/efectos adversos , Ensayos de Uso Compasivo , Dabigatrán , Femenino , Hematoma/inducido químicamente , Heparina de Bajo-Peso-Molecular/efectos adversos , Heparina de Bajo-Peso-Molecular/uso terapéutico , Humanos , Persona de Mediana Edad , Recurrencia , Trombofilia/tratamiento farmacológico , Trombofilia/etiología , Trombosis de la Vena/etiologíaAsunto(s)
Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Monoclonales/efectos adversos , Lupus Eritematoso Cutáneo/tratamiento farmacológico , Adulto , Anticuerpos Monoclonales Humanizados , Femenino , Humanos , Prevención Secundaria , Índice de Severidad de la Enfermedad , Resultado del TratamientoAsunto(s)
Vendajes , Enfermedades de la Uña/terapia , Niño , Humanos , Masculino , Inducción de RemisiónRESUMEN
Congenital erosions and vesicles that heal with reticulate scarring comprise a new entity first described in 1985 in 3 girls aged 3, 5 and 6 years. Two years later, an 8-year-old boy in whom the skin lesions were accompanied by neurological disorders was described, as in one of the patients described in the 1985 study. In 1990, similar findings were reported in a neonate, and recently the 7th case has been reported in the American literature. We describe an 8-month-old infant born with cutaneous lesions that subsequently formed reticulate scars peculiar to this clinical entity, which is characterized by variable clinical and histological expression.
Asunto(s)
Cicatriz/etiología , Enfermedades Cutáneas Vesiculoampollosas/congénito , Tejido Adiposo/patología , Vesícula/congénito , Vesícula/patología , Cicatriz/patología , Estudios de Seguimiento , Humanos , Hipopigmentación/etiología , Hipopigmentación/patología , Lactante , Masculino , Esclerosis , Enfermedades Cutáneas Vesiculoampollosas/patología , Úlcera Cutánea/congénito , Úlcera Cutánea/patología , Cicatrización de HeridasRESUMEN
BACKGROUND: Leiomyomas are rare, benign tumors that originate from the arrector muscle of hair follicles (cutaneous leiomyoma, piloleiomyoma), the tunica dartos of the scrotum and the mammillary muscle of the nipple (genital leiomyoma), and the smooth muscle of blood vessels (angioleiomyoma). OBSERVATIONS: We describe 6 members of a single family with mostly painful papulonodular cutaneous lesions on the limbs, trunk and face. Histological examination of sections stained with hematoxylin-eosin and Masson trichromic stain confirmed the diagnosis of leiomyoma. All affected women had also uterine myoma. CONCLUSION: Our observations support the concept that this entity is an autosomally inherited disorder.